South & Central America Forced Oscillometry Market is expected to reach US$ 4,771.3 Thousand by 2034

According to The Insight Partners' research, the South and Central America Forced Oscillometry Market was valued at US$ 3,242.3 Thousand in 2025 and is expected to reach US$ 4,771.3 Thousand by 2034, registering a CAGR of 4.5% from 2026 to 2034.

Government initiatives, reimbursement expansion, and the rise of hybrid oscillometry systems are among the critical factors driving growth in the South & Central America forced oscillometry market.

The World Health Organization’s Package of Essential Noncommunicable Disease Interventions (WHO PEN) for primary health care explicitly includes guidance on the diagnosis and long-term management of asthma and COPD in low-resource settings, creating a policy foundation for effort-independent tests such as oscillometry in community clinics. Brazil’s Strategic Action Plan for Tackling Chronic Non-Communicable Diseases (NCDs) and Health Promotion (2021–2030) focuses on reducing premature deaths from major NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases through health promotion, risk-factor reduction, population screening, disease surveillance, and strengthening primary healthcare under Brazil’s Unified Health System (SUS). Similar NCD strategies in other emerging economies align with WHO PEN recommendations, promoting primary-care strengthening and inclusion of advanced yet simple diagnostics. 

As governments expand universal health coverage, telemedicine reimbursement, and chronic-disease screening programmes, forced oscillometry gains traction as a cost-effective, patient-friendly complement to spirometry. This policy momentum, combined with dedicated CPT coding and international primary-care frameworks, removes financial and regulatory barriers, enabling wider deployment in both high-income and low-resource health systems and improving outcomes for millions living with chronic respiratory diseases.

On the contrary, high equipment and maintenance costs hamper the growth of the South & Central America forced oscillometry market.

South and Central America Forced Oscillometry Market Segmentation Analysis:

• By Product, the South and Central America Forced Oscillometry Market is segmented into Device and Accessories. The Device segment is projected to expand at a CAGR of 3.4% during 2026 - 2034.
• By Device For Product, the South and Central America Forced Oscillometry Market is segmented into Desktop and Portable. The Desktop segment is projected to expand at a CAGR of 3.2% during 2026 - 2034.
• By Accessories For Product, the South and Central America Forced Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment is projected to expand at a CAGR of 7.1% during 2026 - 2034.
• By Application, the South and Central America Forced Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment is projected to expand at a CAGR of 4.8% during 2026 - 2034.
• By End User, the South and Central America Forced Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment is projected to expand at a CAGR of 4.7% during 2026 - 2034.

By country, the South and Central America Forced Oscillometry Market is categorized into Brazil, Argentina, and the Rest of South and Central America. Brazil is projected to expand at a CAGR of 4.9% during 2026 - 2034.

Key players operating in the Forced Oscillometry Market are COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, IngMar Medical, GANSHORN Medizin Electronic GmbH, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl, among others.

• In April 2025, Cognita Labs partners with forward-thinking clinics to help them evaluate routine lung function screening as a standard part of care. These collaborations generate measurable, real-world insights not just about technology, but about how earlier detection improves outcomes without disrupting workflows.